secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cellectar Biosciences, Inc. (CLRB)
CIK:        0001279704
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001104659-24-009664
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cellectar reports share count update after warrant exercises; 30.45M common shares outstanding as of Jan 31, 2024
--------------------------------------------------------------------------------

- Common shares outstanding: 30,452,042 as of January 31, 2024, up from prior count due to Tranche A and other warrant exercises since November 2023.
- Preferred stock outstanding: 319.76 Series E-2, 918.00 Series E-3, and 111 Series D preferred shares.
- Warrant exercises increased share count, diluting existing common stockholders.
- No business updates or financial results provided; filing solely updates capital structure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1279704/000110465924009664/0001104659-24-009664-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1279704/000110465924009664/tm244672d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-009664

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer